Related by context. All words. (Click for frequent words.) 73 bypass graft CABG surgery 72 perioperative mortality 72 undergoing coronary artery 71 undergone radical prostatectomy 71 coronary artery bypass grafts 71 revascularization procedures 71 postoperative morbidity 71 coronary intervention 71 Coronary artery bypass graft 70 Coronary Artery Bypass Graft 70 postoperative mortality 70 thromboembolic 70 aldosterone antagonist 70 postoperative complication 70 underwent CABG 70 carotid stenosis 70 coronary interventions 69 carotid surgery 69 intravesical therapy 69 revascularisation 69 noncardiac 69 symptomatic VTE 69 NSTE ACS 69 β blockers 69 postoperative infections 69 CABG surgeries 69 liver resection 69 underwent resection 69 dalteparin 68 stenoses 68 deep venous thromboses 68 antiarrhythmic drug 68 LAGB 68 non valvular atrial 68 CYPHER Stent 68 symptomatic intracranial 68 preoperative chemotherapy 68 venous thromboembolic disease 68 revascularization procedure 68 nondiabetic patients 68 bypass grafting 68 colorectal adenoma 68 thromboembolism 68 underwent coronary angiography 68 thromboprophylaxis 68 vaginal hysterectomy 68 revascularizations 68 binary restenosis 68 coronary revascularization 68 aspirin clopidogrel 68 multivessel disease 67 radical nephrectomy 67 VTE prophylaxis 67 perioperative complications 67 patients undergoing percutaneous 67 endarterectomy 67 treated nonsurgically 67 postoperative atrial fibrillation 67 GP IIb IIIa inhibitors 67 hemodialysis patients 67 chemoradiotherapy 67 UPPP 67 thromboembolic events 67 glycoprotein IIb IIIa inhibitors 67 paclitaxel eluting stents 67 VATS lobectomy 67 perioperatively 67 beta blocker therapy 67 OPCAB 67 conventional angiography 67 ischemic cardiomyopathy 67 recurrent glioblastoma multiforme 67 ejection fractions 67 revascularized 67 Doxil ® 67 neurologic complications 67 antithrombotic therapy 67 adjuvant radiotherapy 67 oncologic outcomes 67 reinfarction 67 LV dysfunction 67 nicardipine 67 antiplatelet medication 66 postoperative chemotherapy 66 PCIs 66 nephrectomies 66 functional mitral regurgitation 66 Radical prostatectomy 66 thromboembolic complications 66 ATACAND 66 ß blockers 66 cilostazol 66 radiotherapy RT 66 NATRECOR ® 66 stratifying patients 66 angioplasty stenting 66 prostate TURP 66 salpingo oophorectomy 66 upper gastrointestinal bleeding 66 TAXUS Express Stent 66 liver transplant recipients 66 elective PCI 66 TURBT 66 coronary revascularization procedures 66 periprocedural 66 artery stenosis 66 Adjunctive 66 locoregional recurrence 66 nonvertebral fracture 66 everolimus eluting stents 66 transrectal ultrasound guided 66 postoperative AF 66 recurrent DVT 66 acute myocardial infarction MI 66 dose atorvastatin 66 lipid lowering agents 66 carotid artery stenting 66 spinal metastases 66 histologically confirmed 66 taxane resistant 66 hepatorenal syndrome 66 thrombocytopenic 66 reoperations 66 undergoing coronary angiography 66 carotid artery stenosis 66 percutaneous interventions 66 extracranial 66 advanced adenomas 66 NMIBC 66 noncardiovascular mortality 66 patients undergoing noncardiac 66 underwent surgical resection 66 rFVIIa 66 IOP lowering 66 acute myocardial infarction AMI 66 total abdominal hysterectomy 66 pacemaker implantation 66 pelvic lymphadenectomy 66 cinacalcet 66 graft occlusion 65 aortic insufficiency 65 stenting procedures 65 incomplete revascularization 65 transabdominal 65 Coronary artery bypass 65 morphometric vertebral fractures 65 stable angina 65 thrombotic complications 65 perioperative morbidity 65 occlusive disease 65 cytoreductive surgery 65 TAVR 65 atherothrombosis 65 catheter angiography 65 anticoagulation therapy 65 oxycodone CR 65 KRAS mutations occur 65 Carotid endarterectomy 65 postoperative radiotherapy 65 renal transplants 65 pT3 65 cerebral angiography 65 transurethral 65 revascularisation procedures 65 carotid artery stenting CAS 65 endoscopic remission 65 pneumonectomy 65 underwent percutaneous coronary 65 oral antidiabetic medication 65 TMP SMX 65 neurocognitive outcomes 65 symptomatic carotid stenosis 65 transarterial 65 NSTEMI 65 gastrectomy 65 percutaneous transluminal coronary angioplasty 65 lung resection 65 tenecteplase 65 Stent thrombosis 65 tamoxifen Nolvadex ® 65 histological subtype 65 adrenalectomy 65 intravenous bisphosphonates 65 PRADAXA #mg 65 onset atrial fibrillation 65 pCR 65 artery bypass 65 thiazide diuretic 65 antiplatelet drugs 65 Erythropoietic therapies may 65 bilateral oophorectomy 65 myelodysplastic myeloproliferative diseases 65 tirofiban 65 antiplatelet medications 65 definite stent thrombosis 65 femoral neck fracture 65 hip resurfacing arthroplasty 65 carotid endarterectomy CEA 65 embolizations 65 systolic dysfunction 65 Mitral valve repair 65 rt PA 65 Coronary artery bypass grafting 65 MACCE 65 renal tumors 65 malignant neoplasm 65 placebo dexamethasone 65 debulking surgery 65 paroxysmal AF 65 subtrochanteric 65 detrusor overactivity 65 postoperative infection 65 Thal Dex 65 pancreatectomy 65 cryptogenic stroke 65 nadolol 65 prostate carcinoma 65 ximelagatran 65 chronic thromboembolic pulmonary 65 thymectomy 65 adenomatous 65 carotid revascularization 65 rosuvastatin #mg 65 intracranial stenosis 64 resections 64 STRIDE PD 64 clinically localized prostate 64 XIENCE V demonstrated 64 pretest probability 64 ICD therapy 64 FluCAM arm 64 silent ischemia 64 XIENCE V PROMUS Stent 64 mycophenolate mofetil MMF 64 diagnostic angiography 64 TKAs 64 invasive coronary angiography 64 recurrent VTE 64 adjuvant radiation 64 unstable angina pectoris 64 hip BMD 64 undergoing radical prostatectomy 64 prospective multicenter study 64 percutaneous coronary interventions 64 Cystectomy 64 unstable angina UA 64 lymphadenectomy 64 acute cholecystitis 64 #.#/#.# mmHg [001] 64 parathyroidectomy 64 NNT = 64 PLX STROKE targeting 64 randomizing patients 64 EBUS FNA 64 total thyroidectomy 64 laparoscopically assisted 64 PSA nadir 64 intrathoracic 64 colorectal liver metastases 64 chemoradiation therapy 64 non splenectomized 64 radical cystectomy 64 polyp recurrence 64 primary aldosteronism 64 carotid stents 64 renal artery stenting 64 resectable 64 histologic subtype 64 papillary renal cell carcinoma 64 hyperphenylalaninemia HPA due 64 cerebrovascular events 64 primary percutaneous coronary 64 postoperative pulmonary 64 CABG surgery 64 ARCOXIA 64 hepatectomy 64 micafungin 64 GnRH agonists 64 fibrinolytic therapy 64 preserved ejection fraction 64 drotrecogin alfa activated 64 anticoagulant warfarin 64 myocardial infarctions 64 anticoagulant medications 64 urothelial cancer 64 relapsed MM 64 tuberous sclerosis TS 64 esophageal gastric 64 pretransplant 64 thoracoscopic lobectomy 64 beta blockers ACE inhibitors 64 UA NSTEMI 64 metastatic malignant 64 lipid lowering therapy 64 aortic root replacement 64 eptifibatide 64 mL/min/#.# m 2 64 prospectively evaluated 64 CYPHER ® 64 angiographic outcomes 64 Ejection Fraction 64 intracranial atherosclerosis 64 NAVISTAR R 64 variceal bleeding 64 coronary blockages 64 carotid endarterectomy 64 underwent angiography 64 elevated triglyceride levels 64 BENICAR HCT 64 NATRECOR R 64 cirrhotic patients 64 renal biopsy 64 thrombotic events 64 Postoperative complications 64 cerebral vasospasm 64 recurrent venous thromboembolism 64 acute coronary syndromes ACS 64 leiomyomas 64 CTEPH 64 FFR guided 64 chemoembolization 64 thoracic aortic 64 infarction NSTEMI 64 video assisted thoracoscopic 64 candesartan cilexetil 64 drug eluting stent implantation 64 HER2 expression 64 Taxus Stent 64 RYGB 64 acute myocardial infarctions 64 nonfatal MI 64 ARIXTRA 64 chronic idiopathic thrombocytopenic purpura 64 cystectomy 64 carotid IMT 64 allogeneic HSCT 64 postoperative complications 64 Cypher Stent 64 antiarrhythmic drugs 64 asymptomatic carotid stenosis 64 Carotid Revascularization Endarterectomy vs. 64 aldosterone antagonists 64 cytoreduction 64 intracerebral hemorrhage ICH 64 colectomy 64 STEMI patients 64 dyslipidaemia 64 surgical revascularization 64 multimodality therapy 64 Mitomycin C 63 retrospectively analyzed 63 unresectable tumors 63 peritoneal cancer 63 hemodynamically significant 63 serum phosphorous 63 DES implantation 63 lung resections 63 underwent radical cystectomy 63 intraoperative complications 63 prednisone prednisolone 63 resectable pancreatic cancer 63 salmeterol fluticasone 63 allogeneic hematopoietic stem cell 63 severe aortic stenosis 63 serum calcium levels 63 mitral valve replacement 63 endometrial carcinoma 63 Angiographic 63 aortic valve replacements 63 PSADT 63 LHRH receptor positive 63 intracoronary 63 sirolimus stent 63 hepatic resection 63 atherothrombotic disease 63 pancreatic adenocarcinoma 63 oral anticoagulation 63 statistically significant p = 63 immunosuppressive regimen 63 ICD shocks 63 ALND 63 elevated troponin 63 thoracic aortic aneurysms 63 MitraClip device 63 ICD implants 63 hysterectomies performed 63 thrombolytic agents 63 urothelial carcinoma 63 advanced adenoma 63 baseline LDH 63 arteriography 63 SLNB 63 vertebral fracture 63 coronary artery stenosis 63 ACE Inhibitor 63 ipsilateral breast 63 Cardiopulmonary bypass 63 ischemic complications 63 systemic hypotension 63 inotropic therapy 63 transthoracic 63 recurrent myocardial infarction 63 achieved ACR# 63 bladder augmentation 63 balloon valvuloplasty 63 lipid lowering drugs 63 glycoprotein IIb IIIa inhibitor 63 transcranial Doppler ultrasound 63 pericardial effusion 63 bivalirudin alone 63 coronary artery bypass grafting 63 atorvastatin #mg 63 nonoperative 63 percutaneous vertebroplasty 63 warfarin therapy 63 Abciximab 63 antiplatelet therapy 63 TACE 63 decompensated heart failure 63 osteoporotic compression fractures 63 esophagogastric 63 coronary stenting 63 infarct size 63 computed tomography angiography 63 urodynamic 63 esophageal resection 63 BRCA1 mutation carriers 63 symptomatic BPH 63 inguinal hernia repair 63 NYHA Class II 63 pulmonary artery banding 63 unfractionated heparin UFH 63 PRADAXA 63 HMG CoA reductase inhibitors 63 cholecystectomy 63 nonvertebral fractures 63 carotid artery blockage 63 fluvastatin 63 Statin therapy 63 multivariable adjusted 63 Aprotinin 63 pamidronate 63 pT2 63 left ventricular dysfunction 63 esophagectomy 63 Accelerated Partial Breast Irradiation 63 tipranavir r 63 nonischemic 63 laparoscopic adjustable gastric banding 63 thromboembolic disease 63 hepatic metastases 63 reteplase 63 postintervention 63 acute renal 63 postsurgical 63 daily subcutaneous injections 63 nephron sparing surgery 63 arterial thromboembolic events 63 HIV HCV coinfected 63 IPAH 63 restenosis reblockage 63 gastroduodenal 63 liver metastasis 63 skeletal metastases 63 interstitial brachytherapy 63 Spectranetics laser 63 ICDs implanted 63 post thrombotic syndrome 63 noncardiac surgery 63 repeat revascularization 63 unfractionated heparin 63 lumbar spine BMD 63 unresectable HCC 63 TAXUS Liberte Long 63 aromatase inhibitors AIs 63 argatroban 63 dose statin therapy 63 transapical 63 DAPT 63 revascularization 63 neoadjuvant chemotherapy 63 biochemical recurrence 63 carotid stenting 63 transplantation HCT 63 mycophenolate mofetil 63 CIMZIA TM certolizumab pegol 63 Complication rates 63 interferon ribavirin 63 nodal metastases 63 underwent radical prostatectomy 63 cardiovascular hospitalizations 63 macrovascular events 63 abdominal hysterectomy 63 poor metabolizers 63 certolizumab 63 ablation procedures 63 ertapenem 63 deep vein thromboses 63 mixed hyperlipidemia 63 intravitreal injections 63 paricalcitol 63 intracerebral hemorrhage 63 CABG coronary artery 62 antireflux surgery 62 invasive ductal 62 radioiodine therapy 62 PASI scores 62 ZACTIMA 62 laparoscopic cholecystectomy 62 androgen suppression 62 platelet reactivity 62 cardiopulmonary bypass CPB 62 pulmonary resection 62 myocardial viability 62 undergoing CABG 62 antiangiogenic therapy 62 receiving VICTRELIS 62 ropivacaine 62 postprocedure 62 adult chronic ITP 62 Operative mortality 62 gefitinib Iressa 62 diagnostic modality 62 hematopoietic cancers 62 pancreatic resection 62 irbesartan 62 crossclamp 62 pain palliation 62 CLL SLL 62 advanced neoplasia 62 sirolimus eluting 62 ketorolac 62 AGILECT R 62 bowel resection 62 anticoagulants blood thinners 62 cardiac resynchronisation therapy 62 reintervention 62 ABCB1 62 severe mitral regurgitation 62 radiochemotherapy 62 thyrotoxicosis 62 NYHA functional class 62 ARB telmisartan 62 thrombolytic therapy 62 Adjuvant chemotherapy 62 Thrombolysis 62 bi ventricular pacing 62 gynecologic procedures 62 EUS FNA 62 simvastatin ezetimibe 62 anticlotting drugs 62 receiving highly emetogenic 62 nonoperative treatment 62 sacral nerve stimulation 62 Nesiritide 62 osteosarcomas 62 nonrandomized 62 corticosteroid dose 62 undergoing cardiac catheterization 62 ABSORB trial 62 glycated hemoglobin levels 62 concomitant medications 62 DVT PE 62 tolterodine ER 62 HoLEP 62 haematologic 62 BEXXAR Therapeutic Regimen 62 methotrexate monotherapy 62 Events MACE 62 Renal Cell Carcinoma RCC 62 squamous histology 62 mutated K ras 62 biliary tract cancer 62 echocardiographic parameters 62 smoldering myeloma 62 somatostatin analog 62 infective endocarditis 62 MGd 62 coronary stenosis 62 pulmonary metastases 62 ICD implantation 62 glomerular filtration 62 cardiovascular hospitalization 62 glucocorticoid therapy 62 elevated LDL cholesterol 62 Ebstein anomaly 62 tumor histology 62 portal vein thrombosis 62 nonalcoholic steatohepatitis NASH 62 severe exacerbations 62 atherosclerotic renal artery stenosis 62 Skin sterol 62 intra arterial 62 IIIa inhibitor 62 liposomal amphotericin B 62 sacrocolpopexy 62 carotid plaque 62 low dose Iluvien 62 thyrotropin levels 62 hemorrhagic complications 62 hormone receptor negative 62 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 62 prolonged QT interval 62 NYHA Class III 62 prospectively enrolled 62 meniscectomy 62 endocrine therapies 62 retrospectively reviewed 62 treat NNT 62 thyroidectomy 62 preterm newborns 62 Patients Receiving 62 coronary revascularisation 62 serum creatinine levels 62 angioplasties stents 62 Hypotension 62 Ishak fibrosis score 62 undetectable HBV DNA 62 EXJADE 62 radical prostatectomy RP 62 prostate cancer CaP 62 oral hypoglycemic agent 62 fibrinolysis 62 CIMZIA ™ 62 incisional 62 ruptured aneurysms 62 retrospective cohort 62 refractory ischemia 62 MULTAQ 62 BoNTA 62 relapsing remitting MS RRMS 62 histologically proven 62 ACTEMRA TM 62 LV ejection fraction 62 adjuvant therapies 62 clopidogrel Plavix 62 chemoradiation 62 TNF antagonist 62 myocardial infarction ventricular fibrillation 62 carotid artery stent 62 tibolone 62 sirolimus eluting stents 62 Navelbine 62 underwent prostate biopsy 62 Fontan procedure 62 antibiotic prophylaxis 62 Acute Coronary Syndromes ACS 62 Acute Myocardial Infarction AMI 62 peri procedural 62 dobutamine 62 Subgroup analysis 62 immunomodulatory therapy 62 cranial radiation 62 pelvic radiotherapy 62 T2DM 62 rebleeding 62 bilateral orchiectomy 62 bovine thrombin 62 preoperative radiotherapy 62 Unstable Angina 62 cholecystectomies 62 extrapleural pneumonectomy 62 oral hypoglycemic agents 62 idraparinux 62 receiving prophylactic anticoagulation 62 renal scarring 62 biochemical relapse 62 BCG refractory 62 LHRH agonists 62 ADHF 62 Percutaneous Transluminal Coronary Angioplasty 62 inhibitor RG# 62 thrombolytics 62 thromboses 62 FDG PET imaging 62 RE LY ® 62 invasive angiography 62 TEAEs 62 bronchogenic carcinoma 62 valve implantation 62 intravenous RSD# 62 corticosteroid therapy 62 CYPHER R Sirolimus eluting 62 metastatic gastric 62 tumor resection 62 lung esophageal 62 alemtuzumab treated 62 chest radiographs 62 CIPN 62 confidence interval #.#-#.# 62 conventional coronary angiography 62 HIPEC 62 transradial approach 62 infrapopliteal 62 sargramostim 62 coxib 62 acute STEMI 62 obstructive CAD 62 joint arthroplasty 62 Y Gastric Bypass 62 primary hyperparathyroidism 62 symptomatic paroxysmal AF 62 atherothrombotic events 62 intra abdominal abscess 62 myocardial infarction MI 62 coagulation abnormalities 62 glycated hemoglobin HbA1c 62 prognostic variables 62 acromegalic patients 62 angiographic restenosis 62 microvascular disease 62 antiplatelet agents 62 inhospital 62 prostate cancer PCa 62 undergone splenectomy 62 undergoing peritoneal dialysis 62 CsA 62 endoscopic resection 62 liver histology 62 atrioventricular block 61 metastatic pancreatic 61 antiretroviral naïve 61 unresectable liver cancer 61 plasminogen activators 61 imipenem 61 PNH patients 61 underwent liver transplantation 61 elevated transaminases 61 lumbar disk herniation 61 hemoglobin A1c levels 61 subgroup analyzes 61 HER2 positive cancers 61 Breast conserving 61 hepatocellular 61 cervical fusion 61 clinicopathological features 61 Chronic Heart Failure 61 APTIVUS r 61 Carotid artery 61 sternal wound infections 61 calcaneal fractures 61 chorioamnionitis 61 unicompartmental knee arthroplasty 61 #mmHg [001] 61 tibial shaft 61 nonfatal myocardial infarction MI 61 bivalirudin 61 endometrial hyperplasia 61 receiving XGEVA 61 benign nodules 61 Fibrates 61 parous women 61 neoadjuvant treatment 61 angiotensin converting enzyme inhibitor 61 tissue oxygenation 61 transcatheter closure 61 sotalol 61 baseline HbA1c 61 mechanically ventilated patients 61 precancerous cervical 61 androgen deprivation 61 retrospective cohort study 61 coronary angiograms 61 clinically evaluable 61 posttransplant 61 renal transplantation 61 myocardial infarctions MIs 61 metastatic GIST 61 angiographically 61 inotropes 61 Burch colposuspension 61 transapical approach 61 adenotonsillectomy 61 Postoperatively 61 prospectively randomized 61 chronic periodontitis 61 bacterial prostatitis 61 transfemoral 61 angiography CTA 61 everolimus eluting stent 61 concurrent chemoradiation 61 grade squamous intraepithelial 61 GnRH agonist 61 CABG 61 intravascular hemolysis 61 vWD 61 adenoidectomy 61 neointimal hyperplasia 61 HORIZONS AMI trial 61 axillary dissection 61 calcineurin inhibitor 61 alfuzosin 61 androgen ablation 61 renal cell carcinomas 61 Am J Cardiol 61 sUA 61 Intravenous immunoglobulin 61 myocardial infarct size 61 thoracic surgeries 61 receiving VELCADE 61 cardiac dysfunction 61 kidney transplant recipients 61 retroperitoneal 61 hypertension diabetes mellitus 61 Platinol ® cisplatin 61 cranial irradiation 61 perfusion abnormalities 61 GP IIb IIIa inhibitor 61 Warfarin Coumadin 61 bifurcated lesions 61 metastatic neuroendocrine tumors 61 NIHSS score 61 AGGRASTAT ® tirofiban hydrochloride 61 inotropic 61 bypass grafts 61 pharmacologic stress 61 stage IIIb IV 61 normotensive 61 resynchronization therapy 61 recurrent malignant glioma 61 mitoxantrone plus 61 concomitant AEDs 61 labetalol 61 undergoing radical cystectomy 61 landmark ATHENA trial 61 elevated ALT 61 mcg QD 61 ipsilateral stroke 61 TLIF 61 anastomotic leak 61 loop diuretics 61 nadroparin 61 hsCRP levels 61 antithrombotic agent 61 anthracycline therapy 61 arteriovenous malformations 61 Transcatheter aortic valve implantation 61 operable breast cancer 61 needle aspiration 61 Acute Coronary Syndromes 61 variceal hemorrhage 61 malignant lesions 61 serum aminotransferase levels 61 CI #.#-#.# [001] 61 antiarrhythmic medications 61 oral anticoagulant therapy 61 aromatase inhibitor therapy 61 partial meniscectomy 61 prescribed statins 61 myocardial infarction stroke 61 malignant pleural mesothelioma 61 euthyroid 61 wedge resection 61 hemodynamically unstable 61 weekly subcutaneous injections 61 antihypertensive therapy 61 Acute Decompensated Heart Failure 61 morbidity mortality 61 ACEI ARB 61 exhaled NO 61 metastatic malignant melanoma 61 clot busting therapy 61 prospective nonrandomized 61 nonmelanoma skin cancers 61 gemcitabine Gemzar 61 Arch Intern Med 61 recurrent acute pancreatitis 61 plasma creatinine 61 Myocardial Infarction Study 61 wound dehiscence 61 decompressive surgery 61 events MACE 61 Secondary endpoints included 61 thrombo embolic 61 D dimer 61 fatal myocardial infarction 61 CABG procedures 61 cGy 61 antiplatelet therapies 61 systolic hypertension 61 serum sodium levels 61 ventricular tachyarrhythmia 61 abacavir Ziagen 61 multivariate analyzes 61 mg administered orally 61 extracolonic findings 61 neoadjuvant 61 NOLVADEX 61 randomized multicenter trial 61 locoregional 61 LNG IUS 61 colorectal metastases 61 EpCAM expression 61 intracranial hemorrhage ICH 61 metastatic bladder 61 proton MR spectroscopy 61 IFN alfa 61 intracapsular 61 TAXUS Stent 61 ezetimibe simvastatin 61 trabeculectomy 61 RARP 61 parecoxib 61 Gliadel Wafer 61 unfavorable cytogenetics 61 RALP 61 minimally symptomatic 61 EchoCRT 61 CTAP# Capsules 61 axillary node 61 deCODE AF TM 61 flutamide 61 adenoma recurrence 61 polycythemia vera essential thrombocythemia 61 arterial thrombosis 61 troponin T 61 cardiac perfusion 61 gadolinium enhancing lesions 61 CMV seropositive 61 osteoid osteoma 61 HbA1C levels 61 Nonspecific 61 nonobstructive CAD 61 5-fluorouracil/leucovorin 61 mineral density 61 abdominal pelvic 61 atherogenic dyslipidemia 61 percutaneous biopsy 61 HBeAg seroconversion 61 lower extremity amputation 61 cerebral perfusion 61 recanalization 61 mitral regurgitation 61 valvular disease 61 ischemia driven 61 Ischemic 61 Percutaneous Coronary Intervention 61 transcatheter aortic valve implantation 61 BRCA mutation carriers 61 cervical lymph node 61 genotypic resistance 61 recurrent metastatic 61 trials RCTs 61 coronary bypass grafting 61 fallopian tube cancers 61 venous thrombosis 61 pulmonary artery catheterization 61 lumbar disc herniation 61 target lesion revascularizations 61 gallstone disease 61 direct thrombin inhibitors 61 elevated LDH 61 macrovascular disease 61 timepoints 61 biventricular pacing 61 evaluable subjects 61 LEXIVA r 61 MAGE A3 ASCI 61 epidural steroid injections 61 supratentorial 61 ER CHOP 61 nodal metastasis 61 Endometrial 61 radical retropubic prostatectomy 61 gadolinium enhanced 61 nonobstructive 61 mitral insufficiency 61 cerebral infarction 61 osteoporotic vertebral compression fractures 61 nontraumatic 61 ASCUS 61 serum urate levels 61 laparoscopic bariatric 61 overt nephropathy 61 arterial revascularization 61 embolic stroke 61 mild renal insufficiency 61 #Gy 61 ® lenalidomide 61 thrombocytopenic patients 61 breast abscesses 61 atrial arrhythmias 61 intact parathyroid hormone 61 colon resection 61 Index CDAI 61 hyperoxaluria 61 TURP 61 intermittent hemodialysis 61 symptomatic fibroids 61 biventricular 61 biliary tract disease 61 serum triglycerides 61 Liver transplantation 61 penetrating keratoplasty 61 preoperative diagnosis 61 breast carcinoma 61 stented 61 refractory angina 61 descending thoracic